Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality

JAMA Oncol. 2015 Oct;1(7):879-80. doi: 10.1001/jamaoncol.2015.1540.

Authors

Laura E MacConaill¹, Neal I Lindeman¹, Barrett J Rollins²

Affiliations

¹ Department of Pathology, Brigham & Women's Hospital, Boston, Massachusetts2Havard Medical School, Boston, Massachusetts.
² Havard Medical School, Boston, Massachusetts3Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

PMID: 26181886
DOI: 10.1001/jamaoncol.2015.1540

No abstract available

MeSH terms

Biomarkers, Tumor / genetics*
Diffusion of Innovation
Genetic Predisposition to Disease
Genetic Testing / trends*
Humans
Medical Oncology / trends*
Neoplasms / diagnosis
Neoplasms / genetics*
Neoplasms / therapy
Patient Selection
Phenotype
Precision Medicine / trends*
Predictive Value of Tests
Prognosis
Reproducibility of Results

Substances

Biomarkers, Tumor